Additionally, ADGRG3 has been shown to inhibit NF-κB signaling [44], whereas activated NF-κB signaling further promotes alveolar epithelial cell senescence, which ultimately leads to pulmonary fibrosis [45]. Here, ADGRG3 is linked to pulmonary fibrosis.